<scp>COX5A</scp> promotes cell progression and cisplatin‐resistance by alleviating mitochondrial dysfunction in head and neck squamous cell carcinoma

Abstract Mitochondrial metabolic reprogramming is a reason for the cisplatin‐resistant state of head and neck squamous cell carcinoma (HNSCC) and confers cisplatin resistance. The functions of cytochrome c oxidase subunit 5a (COX5A) and its target interferon‐stimulated gene 15 (ISG15) in modulating cellular processes, cisplatin resistance, and mitochondrial impairment in HNSCC were studied in this paper. FaDu and FaDu‐DDP cell lines were cultured and then transfected to achieve COX5A/ISG15 knockdown or COX5A overexpression. Zebrafish xenograft models were employed to validate in vivo. Quantitative real‐time PCR and Western blot were used to assess the expression of COX5A and ISG15. Cell viability, migration, and apoptosis were investigated using CCK‐8, Transwell/Wound healing, and flow cytometry assays. Mitochondrial activities were evaluated based on mitochondrial mass, ATP production efficiency, mitochondrial membrane potential (MMP), and reactive oxygen species (ROS). Our results showed that the expression of COX5A increased in FaDu‐DDP cells. Silencing COX5A suppressed cell viability and migration, induced apoptosis, increased cisplatin sensitivity, and overexpression of COX5A had the opposite effects. COX5A silencing led to mitochondrial dysfunction, including reduced mitochondrial mass, ATP deficiency, decreased MMP, and increased ROS. ISG15 was identified as a downstream molecule negatively regulated by COX5A. ISG15 modulation partially reversed the effects of COX5A on cellular behaviors, cisplatin resistance, and mitochondrial dysfunction. COX5A promotes cell growth and enhances cisplatin resistance in HNSCC. These effects are mediated through the regulation of mitochondrial function via the downstream effector ISG15. Thus, our findings demonstrated that COX5A‐mediated mitochondrial bioenergetics are suitable targets for enhancing the cisplatin sensitivity of HNSCC.

Authors

Institutions

Publication Details

Journal
Precision Medical Sciences
Published
2026-06-17
DOI
https://doi.org/10.1002/prm2.70043
Primary Topic
interferon and immune responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

COX5A promotes cell progression and cisplatin‐resistance by alleviating mitochondrial dysfunction in head and neck squamous cell carcinoma

Zhangyu Yao, Yanbin Zhao, Bo Gui, Fangzhou Liu et al.
Precision Medical Sciences
interferon and immune responses
article

COX5A promotes cell progression and cisplatin‐resistance by alleviating mitochondrial dysfunction in head and neck squamous cell carcinoma

Zhangyu Yao, Yanbin Zhao, Bo Gui, Fangzhou Liu, Nannan Guo, Tingting Hu, Qingya Sun, Yihan Tang
article en

Abstract

Abstract Mitochondrial metabolic reprogramming is a reason for the cisplatin‐resistant state of head and neck squamous cell carcinoma (HNSCC) and confers cisplatin resistance. The functions of cytochrome c oxidase subunit 5a (COX5A) and its target interferon‐stimulated gene 15 (ISG15) in modulating cellular processes, cisplatin resistance, and mitochondrial impairment in HNSCC were studied in this paper. FaDu and FaDu‐DDP cell lines were cultured and then transfected to achieve COX5A/ISG15 knockdown or COX5A overexpression. Zebrafish xenograft models were employed to validate in vivo. Quantitative real‐time PCR and Western blot were used to assess the expression of COX5A and ISG15. Cell viability, migration, and apoptosis were investigated using CCK‐8, Transwell/Wound healing, and flow cytometry assays. Mitochondrial activities were evaluated based on mitochondrial mass, ATP production efficiency, mitochondrial membrane potential (MMP), and reactive oxygen species (ROS). Our results showed that the expression of COX5A increased in FaDu‐DDP cells. Silencing COX5A suppressed cell viability and migration, induced apoptosis, increased cisplatin sensitivity, and overexpression of COX5A had the opposite effects. COX5A silencing led to mitochondrial dysfunction, including reduced mitochondrial mass, ATP deficiency, decreased MMP, and increased ROS. ISG15 was identified as a downstream molecule negatively regulated by COX5A. ISG15 modulation partially reversed the effects of COX5A on cellular behaviors, cisplatin resistance, and mitochondrial dysfunction. COX5A promotes cell growth and enhances cisplatin resistance in HNSCC. These effects are mediated through the regulation of mitochondrial function via the downstream effector ISG15. Thus, our findings demonstrated that COX5A‐mediated mitochondrial bioenergetics are suitable targets for enhancing the cisplatin sensitivity of HNSCC.

Precision Medical Sciences
Jiangsu Cancer Hospital (CN)
Openalex Percentile: Top 13%
interferon and immune responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.